Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05492916 · ClinicalTrials.gov registry record · NA

Integrating Cultural Aspects Into Diabetes Education

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT05492916 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05492916, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The goal of this study is to examine the efficacy of the video-based Diabetes Prevention Program (DPP) + Community-supported agriculture (CSA) (hereafter INCLUDE) intervention compared with a wait-list control group (hereafter CONTROL) on diabetes prevention among Chinese immigrants with T2D in NYC. Participants will be randomized with equal allocation to one of the two groups. The INCLUDE group will receive one culturally tailored DPP brief video/week for 24 weeks delivered via WeChat. They will also have access to the CSA program that Co-I Dr. Stella Yi has built in existing and ongoing community-partnered work in Brooklyn Chinatown. The CONTROL group will continue to receive their usual care and, at the end of the study, they will receive DPP videos. Measurements will occur at baseline, 3, and 6 months. This study will provide critical information on whether it is efficacious to use an existing social media platform plus CSA support to enhance access to DPP. If the intervention is proven efficacious, this project can provide important data for future scaling of this intervention. This study may serve as a transformative new model to enhance access to culturally tailored diabetes education and promote health equity for underserved limited English proficiency (LEP) immigrant and minority groups.

Interventions

  • BEHAVIORAL Diabetes Prevention Program (DPP)
  • BEHAVIORAL Community-Supported Agriculture (CSA)

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-04-30
Est. Completion 2025-05-07
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05492916

The ClinicalTrials.gov registry entry for NCT05492916 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Diabetes Prevention Program (DPP) is the first listed.

NCT05492916 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05492916 about?

NCT05492916 is a clinical study titled "Integrating Cultural Aspects Into Diabetes Education". The goal of this study is to examine the efficacy of the video-based Diabetes Prevention Program (DPP) + Community-supported agriculture (CSA) (hereafter INCLUDE) intervention compared with a wait-list control group (hereafter CONTROL) on diabetes prevention among Chinese immigrants with T2D in NYC....

What is the current status of trial NCT05492916?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2023-04-30. Estimated completion is 2025-05-07.

What interventions are being tested in trial NCT05492916?

The interventions under investigation include: Diabetes Prevention Program (DPP) (BEHAVIORAL), Community-Supported Agriculture (CSA) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05492916?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.